NLS Pharma (Equity)
Funding Details
- Date Award
- May 17, 2025
- Vertical
- Biopharma
- Funding URL
- View Funding Page
- Funding Amount:
- $3,000,000
Company Info
- Company Description
- NLS Pharma is focused on developing therapies for ALS and type 1 diabetes, leveraging a merger with Kadimastem to enhance its capabilities in regenerative medicine and CNS disorders.
- Market
- Regenerative Medicine and CNS Disorders
- Location
- Zurich, Switzerland